Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in heart failure: the DECISION trial
Peter van der Meer, Dirk J van Veldhuisen, Geert H D Voordes, J G P Tijssen et autres
8 citationsEuropean Heart Journal
Henk P. Swart
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
18Publications signalées
4801Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Diabetes Treatment and ManagementHeart Failure Treatment and ManagementAtrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studiesCardiovascular Function and Risk Factors
Publications récentes
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease
S. Nicholls, Donna H. Ryan, John Deanfield, Daniel Ferreira et autres
6 citationsJAMA Cardiology
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan et autres
44 citationsThe Lancet
Real-Life Implementation of Guideline-Recommended Medical Therapy in Heart Failure with Reduced Ejection Fraction: Effects on Prognosis and Left Ventricular Ejection Fraction. Primary results of TITRATE-HF
Jishnu Malgie, Mariëlle I Wilde, Stefan Koudstaal, Robert N. Denham et autres
4 citationsEuropean Journal of Heart Failure
Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trial
Rachel M J van der Velden, Nikki A H A Pluymaekers, Elton Dudink, Justin Luermans et autres
0 citationsClinical Cardiology
Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation
Rachel M J van der Velden, Nikki A H A Pluymaekers, Elton Dudink, Justin Luermans et autres
8 citationsHeart
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event
Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa, Frank Edelmann et autres
84 citationsJAMA Cardiology
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy
Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, David L. DeMets et autres
44 citationsDiabetes Care
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd, John W. Eikelboom et autres
2236 citationsNew England Journal of Medicine
Effects of Danicamtiv, a Novel Cardiac Myosin Activator, in Heart Failure with Reduced Ejection Fraction: Experimental Data and Clinical Results from a Phase 2a Trial
Adriaan A. Voors, Jean‐François Tamby, John G.F. Cleland, Michael J. Koren et autres
108 citationsEuropean Journal of Heart Failure
Randomized, Double-Blind, Placebo-Controlled, Multicentre Pilot Study on the Effects of Empagliflozin on Clinical Outcomes in Patients with Acute Decompensated Heart Failure (EMPA-RESPONSE-AHF)
Kevin Damman, Joost C. Beusekamp, Eva M. Boorsma, Henk P. Swart et autres
463 citationsEuropean Journal of Heart Failure
The yield of long‐term electrocardiographic recordings in refractory focal epilepsy
Marije van der Lende, Johan Arends, Robert J. Lamberts, Hanno L. Tan et autres
22 citationsEpilepsia
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.